Po‐Shun Lee

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trial

Jane C. Davies, Helen Sheridan, Nicholas Bell et al. · The Lancet Respiratory Medicine · 2013 · 224 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Plasma gelsolin is a marker and therapeutic agent in animal sepsis*

Po‐Shun Lee, Aaron B. Waxman, Kara L. Cotich et al. · Critical Care Medicine · 2007 · 129 citations

Veterinary Medicine, Immunology, Physiology +16

Lentiviral Vectors for Gene Therapy of Cystic Fibrosis

Mitchell J. Goldman, Po‐Shun Lee, Joo-Sung Yang et al. · Human Gene Therapy · 1997 · 111 citations

Life Sciences, Cell Biology, Molecular Biology +16

Plasma Gelsolin and Circulating Actin Correlate with Hemodialysis Mortality

Po‐Shun Lee, Kartik Sampath, S. Ananth Karumanchi et al. · Journal of the American Society of Nephrology · 2009 · 109 citations · Full text

Medicine, Nephrology, Dialysis +10

Orkambi® and amplifier co‐therapy improves function from a rare CFTR mutation in gene‐edited cells and patient tissue

Steven V. Molinski, Saumel Ahmadi, Wan Ip et al. · EMBO Molecular Medicine · 2017 · 105 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17